Silence Therapeutics plc: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on Mar 13, 2024 and accepted by EDGAR at Mar 13, 2024, 12:52 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Shares outstanding | At period end2023-12-31 | 118,846,966 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-24-030519. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.